Capricor Therapeutics(DE:4LN2)
€9.72+0.77 (+8.65%)
DE:4LN2
Capricor Therapeutics earnings date
€9.72
At close:+0.77 (+8.65%)
Capricor Therapeutics (4LN2) Q2 2019 Earnings Report
0 Followers
DE:4LN2 Q2 2019 EPS Results
- Actual EPS
- -EUR 0.53
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 1.26
DE:4LN2 Q2 2019 Revenue Results
- Actual Revenue
- EUR 369.80K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +1.58%
Earnings Announcement Details
- Quarter
- Q2 2019
- Date
- 08/06/2019
- Time
- After Close
- Conference Call
- Tuesday, August 6, 2019
DE:4LN2 Upcoming Earnings
Capricor Therapeutics's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2019 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2019 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2019 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:4LN2 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -0.33- | -0.56 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.40-0.66 | -0.49 | -35.19% (-0.17) | |
| Aug 13, 2026 | 2026 (Q2) | -0.53-0.63 | -0.51 | -22.81% (-0.12) | |
| May 12, 2026 | 2026 (Q1) | -0.47-0.53 | -0.48 | -11.32% (-0.05) | |
| Mar 12, 2026 | 2025 (Q4) | -0.46-0.56 | -0.14 | -287.50% (-0.41) | |
| Nov 10, 2025 | 2025 (Q3) | -0.49-0.49 | -0.34 | -42.11% (-0.14) | |
| Aug 11, 2025 | 2025 (Q2) | -0.43-0.51 | -0.32 | -62.86% (-0.20) | |
| May 13, 2025 | 2025 (Q1) | -0.29-0.48 | -0.28 | -70.97% (-0.20) | |
| Mar 19, 2025 | 2024 (Q4) | -0.15-0.14 | -0.02 | -700.00% (-0.13) | |
| Nov 13, 2024 | 2024 (Q3) | -0.32-0.34 | -0.23 | -52.00% (-0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
